The Global Flow Cytometry Market is expected to grow at a CAGR of 8.2% from 2019 to 2027 to reach at $6.36 billion by 2027. Flow cytometry is a widely used method for analyzing cell size & volume, assessing the purity of isolated subpopulations, characterizing & defining different cell types in a heterogeneous cell population, and analyzing the expression of cell surface & intracellular molecules. It allows simultaneous multi-parameter analysis of single cells.
Here are the top 10 companies operating in Flow Cytometry Market–
Agilent Technologies is engaged in providing instruments, software, services, and consumables for the life sciences, diagnostics, and applied chemical markets. The company operates through three business segments, namely, Life Sciences and Applied Markets, Diagnostics & Genomics, and Agilent CrossLab. The company offers flow cytometers, reagents, kits, and accessories through its Diagnostics & Genomics and Life Sciences & Applied segments.
For the Diagnostics and Genomics segment, its manufacturing facilities are situated in California, Colorado, and Texas in the U.S., and in Denmark and Malaysia outside the U.S. The FDA registered sites of the company are placed in California, Colorado, Texas, and Denmark. In 2019, the company had approximately 11,500 customers for its Diagnostics and Genomics business and 23,700 customers for its Life Sciences and Applied Markets business. The company distributes its products through direct sales, e-commerce, resellers, manufacturers’ representatives, and distributors.
Thermo Fisher Scientific
Thermo Fisher Scientific provides analytical instruments, laboratory equipment, lab services, and diagnostics instruments through five brands, namely, Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services. The company operates through four business segments, namely, Laboratory Products & Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company offers reagents, kits, and flow cytometers through its Biosciences business, a part of the Life Sciences Solutions segment under the Invitrogen brand.
The company’s Life Sciences Solutions segment has a direct presence through its operational offices, engineering sites, laboratories, and production sites present in California, New York, Florida, Michigan, Maryland, Illinois, Oregon, Wisconsin, and Pennsylvania within the U.S. and in Lithuania, the U.K., and New Zealand outside the U.S.
Becton, Dickinson and Company
Becton, Dickinson and Company is involved in the developing, manufacturing, and selling of a range of medical supplies, devices, laboratory equipment, and diagnostic products. The company operates through three business segments, namely, BD Medical, BD Life Sciences, and BD Interventional. The company operates in the flow cytometry market through the Biosciences segment (a part of the BD Life Sciences segment). The company caters to hospitals, laboratories and clinics, blood banks, healthcare workers, public health agencies, physicians’ office practices, academic and government institutions, and pharmaceutical and biotechnology companies.
The company has a direct presence in the U.S. China, France, India, Ireland, and Singapore. Its R&D sites are located Bosnia, Herzegovina, Brazil, Canada, China, the Dominican Republic, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Malaysia, Mexico, the Netherlands, Singapore, Spain, and the U.K.
bioMérieux is engaged in designing and developing products in the field of diagnostics, immunotherapy, food safety, and nutrition to fight against infectious diseases and cancers. The company distributes its products for clinical diagnostics, industrial microbiological control – particularly in the agri-food sector, environmental monitoring, veterinary diagnostics, microbial identification, and resistance detection. The company manufactures cell analyzers under the CHEMUNEX brand name.
The company has a direct presence through its production and R&D sites in the U.S., Brazil, France, Spain, Italy, Australia, Germany, India, Belgium, and China and through its subsidiaries in Kenya, the U.S, Norway, Serbia, Chile, Mexico, Brazil, Sweden, Argentina, Vietnam, Thailand, India, China, Canada, Turkey, Russia, Italy, Greece, Germany, Belgium, Singapore, Japan, the U.K., Australia, Spain, the Netherlands, and South Africa.
Beckman Coulter Inc.
Founded in 1935 and headquartered in Brea California, U.S., Beckman Coulter is majorly engaged in the clinical diagnostics industry. The company offers clinical diagnostic products and solutions, automation systems, and clinical information management tools to enhance the diagnostic laboratory’s role in improving patient diagnosis and treatment process. The company offers flow cytometry products for life science solutions.
Beckman Coulter was acquired by Danaher in 2011 and all its operations are conducted under the Life Sciences and Diagnostics segments of Danaher. Danaher operates in four business segments, namely, Life Sciences, Diagnostics, Dental and Environmental, and Applied Solutions. The company offers flow cytometry products through its Life Sciences segment. The manufacturing facilities of the company for life sciences-related products are in North America, Europe, Asia, and Australia.
A report into the projected growth of the current Flow Cytometry Market by Meticulous Research® has produced some incredible forecasts for the industry. By 2027, it’s expected to have grown at a CAGR of 8.2%, reaching over $6.36 billion.
Bio-Rad Laboratories is engaged in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company’s products and solutions are based on technologies to separate, purify, identify, analyze, and amplify biological materials such as cells, bacteria, antibodies, proteins, and nucleic acids. The company operates through two business segments, namely, Life Sciences and Clinical Diagnostics. The company provides flow cytometry products under the Life Sciences segment. The company’s customers include universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories.
The company has a direct presence through its manufacturing, research, and distribution facilities in the U.S., France, Switzerland, Germany, Belgium, Switzerland, and Singapore. The company also has direct distribution channels in over 35 countries through subsidiaries, distributors, and agents. The principal manufacturing and research facilities of the company for the Life Sciences segment are located in California, Singapore, and the U.K.
Luminex is engaged in manufacturing biological testing technologies and products applicable in diverse markets, which include clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. The company operates in two business segments, namely, Clinical and Research & Applied Markets. The company offers flow cytometers, reagents, kits, and software under the Research & Applied Markets segment.
The company sells its Amnis and Guava flow cytometry systems through a direct sales channel in North America, EMEIA, and APAC, and through distribution partners in emerging markets in Southeast Asia, Africa, and Latin America.
Founded in 2009 and headquartered in Massachusetts, U.S., Cytonome/ST manufactures cell sorting systems. The company provides application-specific technologies and solutions in cell purification for the industrial, clinical, and life science markets. The Cytonome Viva-G1 System is used for life science research, the Cytonome Hydris system is used in large-scale cell processing facilities, and the Cytonome Gigasort system is used for cell bioprocessing.
The cell sorting technology known as the jet-in-air or electrostatic droplet is used in sorting systems. The company distributes its products under the trademark—Viva, Hydris, and GigaSort.
Apogee Flow Systems
Incorporated in 2000 and headquartered in Northwood, U.K., Apogee Flow Systems provides three classes of flow cytometry instruments, which include microflow cytometers, universal flow cytometers, and micro-GxP cytometers. Microflow cytometers are used in any analytical flow cytometry application, where the particles of interest are less than 100µm. Universal flow cytometers are suitable for any analytical flow cytometry application, where the particles of interest are in the range 0.5 to 100µm. Micro-GxP cytometers are used in GMP, GLP, and IVD environments.
The company has its distributors in North America, South America, Europe, Asia & Oceania, and the Middle East & Africa.
Established in 1967 as Partec and headquartered in Görlitz, Germany, the company was acquired by Sysmex Corporation and named as Sysmex Partec in 2014. The company manufactures flow cytometry systems, microscopy systems, and reagents & consumables.
Sysmex Corporation offers its products through two business segments, namely, IVD Business and Life Sciences Business. Flow cytometry products are provided under the IVD Business segment. Sysmex Partec is a part of this segment. The IVD Business segment is further classified into Hematology, Hemostasis, Urinalysis, Immunochemistry, Clinical Chemistry, FCM, and Others. The company is present across the Americas, Europe, the Middle East & Africa (EMEA), and Asia-Pacific.
Popular Mention: Miltenyi Biotec B.V. & Co. KG
Authoritative Research on the Flow Cytometry Market – Global Opportunity Analysis and Industry Forecast (2019-2027)
Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.
Please download report pages and learn more: